Found: 33
Select item for more details and to access through your institution.
Quality of life in prostate cancer.
- Published in:
- Prostate, 1987, v. 21, n. S4, p. 145, doi. 10.1002/pros.2990210523
- By:
- Publication type:
- Article
Quality of life of long‐term childhood acute lymphoblastic leukemia survivors: Comparison with healthy controls.
- Published in:
- Psycho-Oncology, 2022, v. 31, n. 12, p. 2159, doi. 10.1002/pon.6060
- By:
- Publication type:
- Article
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
- Published in:
- 1993
- By:
- Publication type:
- journal article
Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1990, v. 82, n. 17, p. 1416
- By:
- Publication type:
- Article
Prognostic value of cytologic parameters in acute myelogenous leukemia.
- Published in:
- 1984
- By:
- Publication type:
- journal article
Long‐term outcome evaluation of medium/high risk acute lymphoblastic leukaemia children treated with or without cranial radiotherapy in the EORTC 58832 randomized study.
- Published in:
- British Journal of Haematology, 2020, v. 189, n. 2, p. 351, doi. 10.1111/bjh.16337
- By:
- Publication type:
- Article
Results of successive EORTC‐CLG 58 881 and 58 951 trials in paediatric T‐cell acute lymphoblastic leukaemia (ALL).
- Published in:
- British Journal of Haematology, 2019, v. 186, n. 5, p. 741, doi. 10.1111/bjh.15983
- By:
- Publication type:
- Article
Elevated fetal haemoglobin is a predictor of better outcome in MDS/ AML patients receiving 5-aza-2′-deoxycytidine (Decitabine).
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 4, p. 609, doi. 10.1111/bjh.14463
- By:
- Publication type:
- Article
Similar efficacy outcomes with peripheral blood stem cell versus bone marrow for autologous stem cell transplantation in acute myeloid leukemia: Long‐term follow‐up of the EORTC‐GIMEMA randomized AML‐10 trial.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 3, p. 486, doi. 10.1002/ajh.27196
- By:
- Publication type:
- Article
Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Different outcome of T cell acute lymphoblastic leukemia with translocation t(11;14) treated in two consecutive children leukemia group EORTC trials.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Idarubicin and cytarabine in combination with gemtuzumab ozogamicin (IAGO) for untreated patients with high-risk MDS or AML evolved from MDS: a phase II study from the EORTC and GIMEMA Leukemia Groups (protocol 06013).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt) - results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Specific scoring systems to predict survival of patients with high-risk myelodysplastic syndrome (MDS) and de novo acute myeloid leukemia (AML) after intensive antileukemic treatment based on results of the EORTC-GIMEMA AML-10 and intergroup CRIANT studies
- Published in:
- Annals of Hematology, 2015, v. 94, n. 1, p. 23, doi. 10.1007/s00277-014-2177-y
- By:
- Publication type:
- Article
Intensive consolidation therapy compared with standard consolidation and maintenance therapy for adults with acute myeloid leukaemia aged between 46 and 60 years: final results of the randomized phase III study (AML 8B) of the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups
- Published in:
- Annals of Hematology, 2012, v. 91, n. 6, p. 825, doi. 10.1007/s00277-012-1436-z
- By:
- Publication type:
- Article
Analysis of surrogate gene expression markers in peripheral blood of melanoma patients to predict treatment outcome of adjuvant pegylated interferon alpha 2b (EORTC 18991 side study).
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 7, p. 1223, doi. 10.1007/s00262-013-1428-4
- By:
- Publication type:
- Article
Validation of Minimal Residual Disease as Surrogate Endpoint for Event-Free Survival in Childhood Acute Lymphoblastic Leukemia.
- Published in:
- JNCI Cancer Spectrum, 2018, v. 2, n. 4, p. N.PAG, doi. 10.1093/jncics/pky069
- By:
- Publication type:
- Article
New drugs in acute myeloid leukemia.
- Published in:
- Drugs & Cell Therapies in Hematology, 2014, v. 2, n. 2, p. 86, doi. 10.4081/dcth.2014.70
- By:
- Publication type:
- Article
Sociodemographic and Medical Determinants of Quality of Life in Long-Term Childhood Acute Lymphoblastic Leukemia Survivors Enrolled in EORTC CLG Studies.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 152, doi. 10.3390/cancers14010152
- By:
- Publication type:
- Article
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3334, doi. 10.3390/cancers12113334
- By:
- Publication type:
- Article
Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Long-term neurotoxicity among childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC Children Leukemia Group studies.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-00869-6
- By:
- Publication type:
- Article
The prognostic value of IKZF1<sup>plus</sup> in B‐cell progenitor acute lymphoblastic leukemia: Results from the EORTC 58951 trial.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 6, p. 1, doi. 10.1002/pbc.30313
- By:
- Publication type:
- Article
Pediatric randomized trial EORTC CLG 58951: Outcome for adolescent population with acute lymphoblastic leukemia.
- Published in:
- Hematological Oncology, 2020, v. 38, n. 5, p. 763, doi. 10.1002/hon.2791
- By:
- Publication type:
- Article
Randomized trial of two schedules of low-dose gemtuzumab ozogamicin as induction monotherapy for newly diagnosed acute myeloid leukaemia in older patients not considered candidates for intensive chemotherapy. A phase II study of the EORTC and GIMEMA leukaemia groups (AML-19)
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 376, doi. 10.1111/j.1365-2141.2010.08095.x
- By:
- Publication type:
- Article
Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: Low incidence of CNS tumours.
- Published in:
- Pediatric Blood & Cancer, 2011, v. 57, n. 1, p. 119, doi. 10.1002/pbc.23083
- By:
- Publication type:
- Article
Overt testicular disease (OTD) at diagnosis is not associated with a poor prognosis in childhood acute lymphoblastic leukemia: Results of the EORTC CLG study 58881.
- Published in:
- Pediatric Blood & Cancer, 2007, v. 49, n. 3, p. 344, doi. 10.1002/pbc.20716
- By:
- Publication type:
- Article
Socio‐economic outcomes among long‐term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: Results of the 58LAE study.
- Published in:
- European Journal of Cancer Care, 2022, v. 31, n. 6, p. 1, doi. 10.1111/ecc.13755
- By:
- Publication type:
- Article
Professor Maurice Staquet, MD, MS (1930 - 2013).
- Published in:
- Statistics in Medicine, 2013, v. 32, n. 30, p. 5219, doi. 10.1002/sim.6034
- By:
- Publication type:
- Article
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2018, v. 110, n. 1, p. 1, doi. 10.1093/jnci/djx133
- By:
- Publication type:
- Article
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA.
- Published in:
- British Journal of Haematology, 1998, v. 102, n. 5, p. 1344
- By:
- Publication type:
- Article
Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC-Childhood Leukaemia Cooperative Group.
- Published in:
- British Journal of Haematology, 1994, v. 86, n. 2, p. 284, doi. 10.1111/j.1365-2141.1994.tb04727.x
- By:
- Publication type:
- Article